Analysts at Goldman Sachs Group assumed coverage on shares of HCA Healthcare (NYSE:HCA) in a research note issued on Wednesday. The firm set a “neutral” rating on the stock.
HCA has been the subject of several other reports. Piper Jaffray Companies restated a “buy” rating and set a $92.00 price target on shares of HCA Healthcare in a research report on Wednesday, October 4th. Jefferies Group cut their price target on shares of HCA Healthcare from $90.00 to $88.00 and set a “buy” rating for the company in a research report on Wednesday, November 1st. ValuEngine upgraded shares of HCA Healthcare from a “hold” rating to a “buy” rating in a research report on Monday, October 2nd. KeyCorp restated a “buy” rating and set a $95.00 price target on shares of HCA Healthcare in a research report on Thursday, September 7th. Finally, SunTrust Banks set a $105.00 price target on shares of HCA Healthcare and gave the company a “buy” rating in a research report on Thursday, December 21st. Three research analysts have rated the stock with a sell rating, six have given a hold rating and eighteen have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $87.60.
Shares of HCA Healthcare (NYSE HCA) traded down $1.08 during trading hours on Wednesday, reaching $85.96. 2,750,200 shares of the company traded hands, compared to its average volume of 2,326,400. HCA Healthcare has a one year low of $71.18 and a one year high of $91.03. The stock has a market capitalization of $30,890.00, a price-to-earnings ratio of 12.23, a PEG ratio of 1.17 and a beta of 0.55. The company has a debt-to-equity ratio of -6.46, a current ratio of 1.68 and a quick ratio of 1.41.
In other news, SVP Victor L. Campbell sold 8,000 shares of the company’s stock in a transaction dated Wednesday, November 8th. The shares were sold at an average price of $78.00, for a total transaction of $624,000.00. Following the completion of the transaction, the senior vice president now directly owns 127,275 shares of the company’s stock, valued at $9,927,450. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Michael S. Cuffe sold 2,150 shares of the company’s stock in a transaction dated Tuesday, October 17th. The shares were sold at an average price of $78.00, for a total transaction of $167,700.00. Following the transaction, the insider now directly owns 12,476 shares of the company’s stock, valued at $973,128. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 22,700 shares of company stock valued at $1,773,872. Insiders own 2.90% of the company’s stock.
Large investors have recently modified their holdings of the company. Northwestern Mutual Wealth Management Co. raised its stake in HCA Healthcare by 14.0% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,163 shares of the company’s stock worth $101,000 after buying an additional 143 shares in the last quarter. Bronfman E.L. Rothschild L.P. raised its stake in HCA Healthcare by 35.1% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 1,232 shares of the company’s stock worth $107,000 after buying an additional 320 shares in the last quarter. Atlantic Trust LLC bought a new position in HCA Healthcare in the second quarter worth about $118,000. Acrospire Investment Management LLC raised its stake in HCA Healthcare by 14.3% in the second quarter. Acrospire Investment Management LLC now owns 1,600 shares of the company’s stock worth $140,000 after buying an additional 200 shares in the last quarter. Finally, BB&T Investment Services Inc. bought a new position in HCA Healthcare in the second quarter worth about $141,000. 75.34% of the stock is owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION WARNING: “HCA Healthcare (HCA) Coverage Initiated at Goldman Sachs Group” was first published by Ticker Report and is the sole property of of Ticker Report. If you are reading this news story on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark laws. The legal version of this news story can be viewed at https://www.tickerreport.com/banking-finance/3127445/hca-healthcare-hca-coverage-initiated-at-goldman-sachs-group.html.
HCA Healthcare Company Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.